本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RAPT Therapeutics, Inc.

33.81
-0.2300-0.68%
盤後34.690.8800+2.60%17:39 EST
成交量:171.04萬
成交額:5,809.76萬
市值:9.37億
市盈率:-5.13
高:35.78
開:33.84
低:33.45
收:34.04
52周最高:42.39
52周最低:5.67
股本:2,771.09萬
流通股本:1,325.56萬
量比:4.28
換手率:12.90%
股息:- -
股息率:- -
每股收益(TTM):-6.5969
每股收益(LYR):-25.4880
淨資產收益率:-85.37%
總資產收益率:-51.35%
市淨率:6.16
市盈率(LYR):-1.33

資料載入中...

2021/05/11

重要事件披露

8-K - Current report
2021/03/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/11

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/11

重要事件披露

8-K - Current report
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/01

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/12/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/11/16

重要事件披露

8-K - Current report
2020/11/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

SEC問詢函

CORRESP [Cover] - Correspondence
2020/10/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/01

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/08/14

重要事件披露

8-K - Current report
2020/08/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/06/22

重要事件披露

8-K - Current report